Nanobiotix
Short position disclosed on October 19, 2026.
Evolution of the disclosed total
January 23, 2018 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Worldquant, LLC | 1.00% | new | October 7, 2026 | |
| Y-Intercept (Hong Kong) Limited | 0.51% | new | October 19, 2026 |
In the United States NBTX (Nasdaq): 146,868 shares sold short on September 30, 2026.NNBXF (OTC): 107,478 shares sold short on September 30, 2026. FINRA names no fund.
On the other side: the funds that hold Nanobiotix Titelia
Get the moves on Nanobiotix by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| May 15, 2019 | Voleon Capital Management LP | 0.59% | July 22, 2019 |
| April 11, 2019 | Voleon Capital Management LP | 0.66% | July 22, 2019 |
| April 11, 2019 | Marshall Wace LLP | 0.00% | April 15, 2019 |
| April 10, 2019 | Marshall Wace LLP | 0.61% | April 15, 2019 |
| April 9, 2019 | Voleon Capital Management LP | 0.73% | July 22, 2019 |
| April 9, 2019 | Marshall Wace LLP | 0.56% | April 15, 2019 |
| April 5, 2019 | Voleon Capital Management LP | 0.69% | July 22, 2019 |
| March 18, 2019 | Voleon Capital Management LP | 0.77% | July 22, 2019 |
| March 14, 2019 | Voleon Capital Management LP | 0.80% | July 22, 2019 |
| March 8, 2019 | Voleon Capital Management LP | 0.70% | July 22, 2019 |
| February 28, 2019 | Voleon Capital Management LP | 0.62% | July 22, 2019 |
| February 22, 2019 | Voleon Capital Management LP | 0.51% | July 22, 2019 |
| September 18, 2018 | Voleon Capital Management LP | 0.41% | September 20, 2018 |
| September 7, 2018 | Voleon Capital Management LP | 0.52% | September 20, 2018 |
| August 7, 2018 | Marshall Wace LLP | 0.49% | August 9, 2018 |
| August 2, 2018 | Marshall Wace LLP | 0.55% | August 9, 2018 |
| July 27, 2018 | Marshall Wace LLP | 0.61% | August 9, 2018 |
| February 28, 2018 | GSA Capital Partners LLP | 0.48% | March 2, 2018 |
| January 23, 2018 | GSA Capital Partners LLP | 0.50% | March 2, 2018 |
Download 69 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Renault 11.50% of the capital sold short
- Valeo 11.37% of the capital sold short
- Ubisoft Entertainment 10.77% of the capital sold short
- Viridien 10.53% of the capital sold short
- FDJ United 6.56% of the capital sold short
- Teleperformance 5.88% of the capital sold short
- Abivax 5.52% of the capital sold short
- Alstom 4.98% of the capital sold short
- Rémy Cointreau 4.66% of the capital sold short
- Atos Group 3.78% of the capital sold short
- Nexity 3.54% of the capital sold short
- DBV Technologies 3.39% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Nanobiotix, source AMF, data as at October 19, 2026, https://www.quivad.com/action/nanobiotix?page=2